Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2010-06-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2010.04.073PMID 20488703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure‐based Drug Metabolism Predictions for Drug Design

  2010cited by this paper
• Cunninghamella--a microbial model for drug metabolism studies--a review.

  2009cited by this paper
• Abstracts, American Chemical Society Division of Chemical Toxicology, 236th ACS National Meeting, Philadelphia, PA, August 17−21, 2008

  2008cited by this paper
• Systolic Hypertension in the Elderly: Pushing the Frontiers of Therapy—A Suggested New Approach

  2004cited by this paper
• In silico ADME prediction: data, models, facts and myths.

  2003cited by this paper
• Cyclic GMP‐dependent vasodilatory properties of LASSBio 294 in rat aorta

  2002cited by this paper
• Transformation of cinoxacin by Beauveria bassiana.

  2002cited by this paper
• The new compound, LASSBio 294, increases the contractility of intact and saponin‐skinned cardiac muscle from Wistar rats

  2001cited by this paper
• Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole.

  2000cited by this paper
• Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl N-acylhydrazone derivatives.

  2000cited by this paper
• Biotransformation of cadinane sesquiterpenes by Beauveria bassiana ATCC 7159.

  2000cited by this paper
• Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?

  1998cited by this paper
• Pharmacokinetics, Metabolism and Interactions of Acid Pump Inhibitors

  1996cited by this paper
• Small intestinal sulphoxidation of albendazole.

  1995cited by this paper
• Microbial models of mammalian metabolism.

  1983cited by this paper
• Microbial models of mammalian metabolism.

  1975cited by this paper
• Microbial models of mammalian metabolism. Aromatic hydroxylation.

  1974cited by this paper

• Effect of S–Se Bioisosteric Exchange on Affinity and Intrinsic Efficacy of Novel N-acylhydrazone Derivatives at the Adenosine A2A Receptor

  2021cites this paper
• Base-promoted regiodivergent allylation of N-acylhydrazones with Morita-Baylis-Hillman carbonates by tuning the catalyst.

  2019cites this paper
• N-Acylhydrazones as drugs.

  2018cites this paper
• Novel chemical scaffolds against Schistosoma mansoni discovered by combi-QSAR, virtual screening, and confirmed by experimental evaluation with automated imaging

  2018cites this paper
• QSAR and Molecular Modeling Approaches for Prediction of Drug Metabolism

  2015cites this paper
• A Importância do Estudo do Metabolismo nos Estágios Iniciais de Desenvolvimento de Fármacos

  2015cites this paper
• In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni

  2015cites this paper
• The Importance of Metabolism Study in the Early Stages of Drugs Development

  2015cites this paper
• In silico prediction of drug metabolism by P450.

  2014cites this paper
• Tuning HERG out: antitarget QSAR models for drug development.

  2014cites this paper
• Virtual screening strategies in medicinal chemistry: the state of the art and current challenges.

  2014cites this paper
• Assessing the performance of 3D pharmacophore models in virtual screening: how good are they?

  2013cites this paper
• Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound.

  2013cites this paper
• UNIVERSIDADE FEDERAL DE GOIÁS FACULDADE DE FARMÁCIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS

  2013cites this paper
• Combination of docking, molecular dynamics and quantum mechanical calculations for metabolism prediction of 3,4-methylenedioxybenzoyl-2-thienylhydrazone

  2012cites this paper
• Determination of the cardioactive prototype LASSBio-294 and its metabolites in dog plasma by LC-MS/MS: application for a pharmacokinetic study.

  2011cites this paper
• Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism

  2011cites this paper
• CYP1A2-mediated biotransformation of cardioactive 2-thienylidene-3,4-methylenedioxybenzoylhydrazine (LASSBio-294) by rat liver microsomes and human recombinant CYP enzymes.

  2011cites this paper